PMDA drug package insert
コアキシン注射用1g
PMDA Prescription drug · 株式会社ケミックス · package insert Feb 26, 2024
Key facts
| Brand names | コアキシン注射用1g, コアキシン注射用2g |
|---|---|
| Nonproprietary names | セファロチンナトリウム |
| Companies | 製造販売元（輸入）／株式会社ケミックス |
| Product type | Prescription drug |
| Therapeutic category | 合成セファロスポリン系抗生物質 |
| Therapeutic category codes | 876132 |
| YJ codes | 6132403D2121, 6132403D3128 |
| Approval numbers | 21800AMX10816000, 21800AMX10815000 |
| Package insert edition | 第1版 |
| Package insert date | Feb 26, 2024 |
| PMDA document key | 260054_6132403D2121_1 |
| PMDA company code | 260054 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: